Rare diseases
Investigational molecules
Locations
Back to Portugal263 clinical trials in Coimbra, Portugal across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy
PortugalStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
PortugalStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
PortugalStudy of Elafibranor for Adults with Primary Biliary Cholangitis
PortugalStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
PortugalStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
PortugalAdjuvant Therapy with RO7435846 (divarasib) versus Pembrolizumab or Nivolumab or Observation in Patients After Surgery for Stage II‑III KRAS G12C NSCLC
PortugalRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
PortugalA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
PortugalEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
PortugalPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
PortugalA double‑blind, placebo‑controlled trial of oral BI 1015550 in patients with systemic sclerosis
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative trials investigating treatments for polypoidal choroidal vasculopathy and thyroid eye disease, focusing on improving visual outcomes and reducing eye-related complications.
Advanced therapeutic approaches using intravitreal injections and targeted medications.
Groundbreaking research addressing various skin conditions including hidradenitis suppurativa, pyoderma gangrenosum, and neurodermatitis.
Novel therapeutic approaches targeting specific inflammatory pathways.
Comprehensive studies exploring treatments for cardiovascular disease and pulmonary arterial hypertension, with focus on preventing major adverse cardiac events.
Innovative therapies targeting specific cardiovascular risk factors.
Advanced research in ischemic stroke, epilepsy, and migraine treatments, exploring both acute interventions and preventive therapies.
Cutting-edge therapeutic approaches for neurological disorders.
Studies focusing on breast cancer, non-small cell lung cancer, and leiomyosarcoma, developing targeted therapies for various cancer types.
Innovative approaches in cancer treatment and management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
